FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, in particular to ophthalmology. An aqueous ophthalmologic solution contains an effective amount of ketorolak, carboxymethyl cellulose in an aqueous solution where said concentration of carboxymethyl cellulose is selected so that to provide higher absorption of ketorolak in a patient's eye which is at least 130 % more than absorption of the reference aqueous ophthalmologic solution of ketorolak with the same concentration of ketorolak with no preservative added.
EFFECT: invention provides anaesthetising and anti-inflammatory activity.
20 cl, 12 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-INFLAMMATORY AND MYDRIATIC INTRA-CHAMBER SOLUTIONS FOR INHIBITION OF POSTOPERATIVE INFLAMMATORY EYE CONDITIONS | 2015 |
|
RU2750296C2 |
| Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
| OPHTHALMIC PHARMACEUTICAL FORMULAE AND THEIR USE | 2017 |
|
RU2791371C2 |
| OPHTHALMIC COMPOSITION WITH VISCOSITY ENHANCEMENT SYSTEM HAVING TWO DIFFERENT VISCOSITY ENHANCING AGENTS | 2012 |
|
RU2601115C2 |
| PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND TRAMADOL FOR OPHTHALMIC APPLICATION | 2014 |
|
RU2694369C2 |
| SUSPENSIONS OF NANOPARTICLES, CONTAINING CARBOXYVINYL POLYMER | 2010 |
|
RU2571078C2 |
| OPHTHALMIC COMPOSITIONS CONTAINING PROSTAMIDE RELEASING NITROGEN OXIDE | 2019 |
|
RU2781022C2 |
| LOW-DOSE BRIMONIDINE COMBINATIONS AND THEIR USE | 2018 |
|
RU2801221C2 |
| OPHTHALMIC GEL BIMATOPROST, WHICH IS APPLIED IN FORM OF DROPS | 2016 |
|
RU2698456C2 |
| COMPOSITION CONTAINING THERAPEUTICALLY ACTIVE INGREDIENTS HAVING INCREASED SOLUBILITY | 2001 |
|
RU2291685C2 |
